TG Therapeutics | TGTX - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 403.83B 5.2B 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Amgen USD 176.25B 24.32B 2025-12
Ardelyx USD 1.42B 89M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Curis USD 3M 10M 2026-04
Gilead Sciences USD 166.62B 14.34B 2026-04
Infinity Pharmaceuticals USD 0 0 2026-04
J&J USD 561.65B 17.5B 2026-04
Karyopharm Therapeutics USD 652M 517M 2026-04
Novartis USD 231.75B 76B 2026-04
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Verastem USD 134M 462M 2026-04
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12